Evidence map›Paper›PMID 29166836›Full record

ArticleMolecular pain

Characterisation of Nav1.7 functional expression in rat dorsal root ganglia neurons by using an electrical field stimulation assay.

Antoine Fouillet, Jake F Watson, Andrew D Piekarz, Xiaofang Huang, Baolin Li, Birgit Priest, Eric Nisenbaum, Emanuele Sher, Daniel Ursu

Open access · goldAbstract read
In one paragraph

Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Downstream Signaling of Muscarinic MPharmacology research & perspectives · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Antoine Fouillet1 Lilly Research Centre, 1539 Eli Lilly and Company , Windlesham, UK.
Jake F Watson1 Lilly Research Centre, 1539 Eli Lilly and Company , Windlesham, UK.ORCID 0000-0002-8698-3823
Andrew D Piekarz2 Lilly Research Laboratories, 1539 Eli Lilly and Company , IN, USA.
Xiaofang Huang2 Lilly Research Laboratories, 1539 Eli Lilly and Company , IN, USA.
Baolin Li2 Lilly Research Laboratories, 1539 Eli Lilly and Company , IN, USA.
Birgit Priest2 Lilly Research Laboratories, 1539 Eli Lilly and Company , IN, USA.
Eric Nisenbaum2 Lilly Research Laboratories, 1539 Eli Lilly and Company , IN, USA.
Emanuele Sher1 Lilly Research Centre, 1539 Eli Lilly and Company , Windlesham, UK.
Daniel Ursu1 Lilly Research Centre, 1539 Eli Lilly and Company , Windlesham, UK.ORCID 0000-0003-3769-0896
Eli Lilly (United States) · USEli Lilly (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The Na

Indexed as

AnimalsCalciumElectric StimulationGanglia, SpinalHippocampusMaleNAV1.7 Voltage-Gated Sodium ChannelRats, Sprague-DawleySensory Receptor CellsSodium Channel BlockersCalciumNAV1.7 Voltage-Gated Sodium ChannelSodium Channel Blockerscalcium imagingdorsal root ganglia neuronselectrical field stimulationNav1.7protoxin-IISodium channels

Identifiers

PMID29166836
PMCPMC5731621
OpenAlexW2769840174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.